• 23. Dezember 2024

Humabs BioMed and the Institute for Research in Biomedicine announce the successful isolation and characterization of a protective, human-derived antibody against Ebola

ByHumabs BioMed

Feb 26, 2016
– International collaboration publishes results in two Science papers
– Clinical development to start with support by DARPA
Teile den Beitrag mit Freunden